Recent Research Development of Imeglimin as Oral Hypoglycemic Agent (OHA) Continue ReadingRecent Research Development of Imeglimin as Oral Hypoglycemic Agent (OHA)
Diabetic Elderly with Keeping Less Arteriosclerosis Treated by Imeglimin (Twymeeg) Continue ReadingDiabetic Elderly with Keeping Less Arteriosclerosis Treated by Imeglimin (Twymeeg)
Latest Pharmaceutical Development of Imeglimin Electrospinning Nanofibers for Diabetic Treatment Continue ReadingLatest Pharmaceutical Development of Imeglimin Electrospinning Nanofibers for Diabetic Treatment
Improvement of HbA1c, Weight and Fatty Liver by Short Treatment of Imeglimin (Twymeeg) Continue ReadingImprovement of HbA1c, Weight and Fatty Liver by Short Treatment of Imeglimin (Twymeeg)
